Abstract
The coronavirus disease 2019 (COVID-19) was recognized as a pandemic on 11 March 2020. However, the median age of laboratory-confirmed cases is about 45 years and age is not a sole potential risk for catching COVID-19; unfortunately, some social media pretend that elderly people are more likely to be infected by COVID-19. Providing such information about the COVID-19 can increase the stress and anxiety among the elderly that may weaken their immune system. It is suggested that social media provide appropriate information to reduce public stress.
Keywords: Ageism, COVID-19, discrimination, elderly people, public health, social media, pandemic.
[http://dx.doi.org/10.12998/wjcc.v8.i4.652] [PMID: 32149049]
[http://dx.doi.org/10.1002/jmv.25748] [PMID: 32134116]
[http://dx.doi.org/10.1111/jocn.15274] [PMID: 32239784]
[http://dx.doi.org/10.1007/s11357-014-9631-6] [PMID: 24562499]
Coronaviruses
Title:The COVID-19 and Ageism in Social Media
Volume: 1 Issue: 1
Author(s): Yadollah Abolfathi Momtaz*
Affiliation:
- Iranian Research Center on Aging, University of Social Welfare and Rehabilitation Sciences, Tehran,Iran
Keywords: Ageism, COVID-19, discrimination, elderly people, public health, social media, pandemic.
Abstract: The coronavirus disease 2019 (COVID-19) was recognized as a pandemic on 11 March 2020. However, the median age of laboratory-confirmed cases is about 45 years and age is not a sole potential risk for catching COVID-19; unfortunately, some social media pretend that elderly people are more likely to be infected by COVID-19. Providing such information about the COVID-19 can increase the stress and anxiety among the elderly that may weaken their immune system. It is suggested that social media provide appropriate information to reduce public stress.
Export Options
About this article
Cite this article as:
Momtaz Abolfathi Yadollah *, The COVID-19 and Ageism in Social Media, Coronaviruses 2020; 1 (1) . https://dx.doi.org/10.2174/2666796701999200621203144
DOI https://dx.doi.org/10.2174/2666796701999200621203144 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
COVID-19: Update on Pathogenesis and Treatment Strategies
Current Immunology Reviews (Discontinued) Current Strategies and Approaches in Combating SARS-CoV-2 Virus that Causes COVID-19
Letters in Drug Design & Discovery Drug Repositioning: A Smart Approach for Combating SARS-CoV-2
Anti-Infective Agents COVID-19 Pandemic: How can Computer-assisted Methods help to Rein in this Global Menace?
Current Computer-Aided Drug Design Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a Patient with Hodgkin's Lymphoma History from North of Iran
Infectious Disorders - Drug Targets Anti-malarial Drugs are Not Created Equal for SARS-CoV-2 Treatment: A Computational Analysis Evidence
Current Pharmaceutical Design SARS-CoV-2: Molecular Biology and Therapeutic Targets
Coronaviruses Development of Anti-Viral Agents Using Molecular Modeling and Virtual Screening Techniques
Infectious Disorders - Drug Targets An Urgent Industrial Scheme Both for Total Synthesis, and for Pharmaceutical Analytical Analysis of Umifenovir as an Anti-viral API for Treatment of COVID-19
Combinatorial Chemistry & High Throughput Screening COVID-19: The Unprecedented Malady- A Holistic Review
Coronaviruses A Review on Post-traumatic Stress Disorder (PTSD): Symptoms, Therapies and Recent Case Studies
Current Molecular Pharmacology Screening for Potential Traditional Herbal Inhibitors Against 3-Chymotrypsin- like Main Protease (3CLpro) from Four Different Coronaviruses: An in silico Approach
Coronaviruses Covid-19 in Man: A Very Dangerous Affair
Endocrine, Metabolic & Immune Disorders - Drug Targets 1+1 > 2: Integration of the Host-directed Traditional Chinese Medicine and the Virus-targeted Modern Medicine in Control of COVID-19
Clinical Cancer Drugs COVID-19 Pandemic: Age and Temperature Related Effects
Coronaviruses Pharmacological Inhibition of MMP3 as a Potential Therapeutic Option for COVID-19 Associated Acute Respiratory Distress Syndrome
Infectious Disorders - Drug Targets An Overall Picture of SARS Coronavirus (SARS-CoV) Genome-Encoded Major Proteins: Structures, Functions and Drug Development
Current Pharmaceutical Design Chemodiversity in Freshwater and Terrestrial Cyanobacteria – A Source for Drug Discovery
Current Drug Targets CORONAVIRUS and COVID-19: A Systematic Review and Perspective
Current Drug Therapy Impact of Online Teaching on Students’ Education and Health in India during the Pandemic of COVID-19
Coronaviruses